DKK1 and neoplasm: When tumours metastasised to bone (but not lung or brain), patients with higher tumour expression of DKK1 had a better outcome than patients whose tumours expressed lower levels of DKK1 (p = 0.01, log rank test of a Cox-proportional hazards model) (Supplementary Fig. 2I).